Hugel and Medica join forces to boost botulinum toxin sales in Middle East, North Africa

• Hugel aims to secure strong business coverage in the region via the strategic partnership 
• The MENA aesthetic market is projected to witness strong growth in the next few years with UAE and Saudi Arabia taking the lead

SEOUL, South Korea, Nov. 21, 2024 /PRNewswire/ -- Hugel Inc., a leading global medical aesthetics company, said on Friday it will spur expansion in the botulinum toxin market of the Middle East and North Africa (MENA) via a strategic partnership with Dubai-headquartered aesthetic and medical distribution partner Medica Group.

The two companies have recently entered into an agreement to bolster the distribution of Hugel's toxin Botulax in the key markets of the region. Hugel, which exports its own toxin to 64 markets including the US, Europe and

Full story available on Benzinga.com